MagnaPharm Baltics UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 0 |
| 0 |
| -25,615 |
| -25,615 |
| -25,615 |
| - |
| - |
| -20,615 |
| 117,110 |
| 0 |
| 96,495 |
| 2023 |
|---|
| 814,264 |
| 183,393 |
| -241,519 |
| -241,519 |
| -54,396 |
| 56.50 |
| -29.66 |
| -262,134 |
| 519,499 |
| 26,966 |
| 313,524 |
| 2024 |
|---|
| 4,648,026 |
| 690,643 |
| 12,732 |
| -24,488 |
| -3,639 |
| 30.04 |
| -0.53 |
| 713,378 |
| 1,874,998 |
| 230,151 |
| 2,572,721 |
Register and
explore Okredo data| 2024 |
|---|
| 4,648,026 |
| 690,643 |
| 12,732 |
| -24,488 |
| -3,639 |
| 30.04 |
| -0.53 |
| 713,378 |
| 1,874,998 |
| 230,151 |
| 2,572,721 |
Register and
explore Okredo data2024
Turnover (€)
4,648,026 €
471 % *
Sales per employee (€)
690,643 €277 % *
Profit before tax (€)
12,732 €105 % *
Net Profit (€)
-24,488 €90 % *
Profit per employee (€)
-3,639 €93 % *
Total profitability (%)
30.04 %
-46.83 % *
Net profitability (%)
-0.53 %98.21 % *
Equity (€)
713,378 €372 % *
Amounts Payable And Liabilities (€)
1,874,998 €
261 % *
Non-current Assets (€)
230,151 €753 % *
CurrentAssets (€)
2,572,721 €721 % *